Literature DB >> 8578203

Reflux esophagitis: overview.

R C Orlando1.   

Abstract

Reflux eosophagitis is one of the most common chronic disorders in humans. While ultimately due to contact of esophageal epithelium with gastric acid and pepsin, the pathogenesis of the condition remains poorly understood. In the present manuscript, some key clinical aspects of this condition are briefly reviewed, including pathogenesis, complications, diagnosis, and treatment.

Entities:  

Mesh:

Year:  1995        PMID: 8578203     DOI: 10.3109/00365529509090267

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  5 in total

Review 1.  Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis.

Authors:  Florian Rieder; Piero Biancani; Karen Harnett; Lisa Yerian; Gary W Falk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-03-18       Impact factor: 4.052

2.  Viewpoints on Acid-induced inflammatory mediators in esophageal mucosa.

Authors:  Karen M Harnett; Florian Rieder; Jose Behar; Piero Biancani
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

3.  Influence of lumbar kyphosis and back muscle strength on the symptoms of gastroesophageal reflux disease in middle-aged and elderly people.

Authors:  Shiro Imagama; Yukiharu Hasegawa; Norimitsu Wakao; Kenichi Hirano; Nobuyuki Hamajima; Naoki Ishiguro
Journal:  Eur Spine J       Date:  2012-02-28       Impact factor: 3.134

4.  Orally administered L-arginine and glycine are highly effective against acid reflux esophagitis in rats.

Authors:  Kenji Nagahama; Hikaru Nishio; Masanori Yamato; Koji Takeuchi
Journal:  Med Sci Monit       Date:  2012-01

5.  Regional Food Causing Symptoms of Gastroesophageal Reflux Disease.

Authors:  Jung Ho Park
Journal:  J Neurogastroenterol Motil       Date:  2017-07-30       Impact factor: 4.924

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.